1 Min Read
Jan 29 (Reuters) - Rexahn Pharmaceuticals Inc:
* REXAHN PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FOR A NEW U.S. PATENT COVERING THE USE OF RX-5902 (SUPINOXIN™) Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.